These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31554835)

  • 21. Geniposide exhibits anticancer activity to medulloblastoma cells by downregulating microRNA-373.
    Chen Z; Liu W; Qin Z; Liang X; Tian G
    J Biochem Mol Toxicol; 2020 May; 34(5):e22471. PubMed ID: 32057176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells.
    Wang Q; Li H; Wang XW; Wu DC; Chen XY; Liu J
    Neurosci Lett; 2003 Nov; 351(2):83-6. PubMed ID: 14583387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development.
    Jiang X; Yang P; Ma L
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10183-8. PubMed ID: 19502428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line.
    Chang Q; Chen Z; You J; McNutt MA; Zhang T; Han Z; Zhang X; Gong E; Gu J
    J Neurooncol; 2007 Sep; 84(3):263-7. PubMed ID: 17453147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells.
    Khoshyomn S; Manske GC; Lew SM; Wald SL; Penar PL
    Pediatr Neurosurg; 2000 Sep; 33(3):123-31. PubMed ID: 11096359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2.
    Wei Z; Hurtt R; Ciccarelli M; Koch WJ; Doria C
    J Cell Physiol; 2012 Jun; 227(6):2371-7. PubMed ID: 21826651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.
    Maynard RE; Poore B; Hanaford AR; Pham K; James M; Alt J; Park Y; Slusher BS; Tamayo P; Mesirov J; Archer TC; Pomeroy SL; Eberhart CG; Raabe EH
    Cancer Lett; 2021 Apr; 504():137-145. PubMed ID: 33571541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastoma.
    Keating J; Tsoli M; Hallahan AR; Ingram WJ; Haber M; Ziegler DS
    Mol Cancer Ther; 2012 Dec; 11(12):2654-63. PubMed ID: 23012247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.
    Ho WS; Feldman MJ; Maric D; Amable L; Hall MD; Feldman GM; Ray-Chaudhury A; Lizak MJ; Vera JC; Robison RA; Zhuang Z; Heiss JD
    Oncotarget; 2016 Mar; 7(11):12447-63. PubMed ID: 26799670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
    Aguilera DG; Das CM; Sinnappah-Kang ND; Joyce C; Taylor PH; Wen S; Hasselblatt M; Paulus W; Fuller G; Wolff JE; Gopalakrishnan V
    J Neurooncol; 2009 Jul; 93(3):303-18. PubMed ID: 19148581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade.
    Robinson JD; Pitcher JA
    Cell Signal; 2013 Dec; 25(12):2831-9. PubMed ID: 24018045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of phosphorylation-dependent and -independent mechanisms in the regulation of histamine H2 receptor by G protein-coupled receptor kinase 2.
    Fernandez N; Gottardo FL; Alonso MN; Monczor F; Shayo C; Davio C
    J Biol Chem; 2011 Aug; 286(33):28697-28706. PubMed ID: 21705320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.
    Sengupta S; Weeraratne SD; Sun H; Phallen J; Rallapalli SK; Teider N; Kosaras B; Amani V; Pierre-Francois J; Tang Y; Nguyen B; Yu F; Schubert S; Balansay B; Mathios D; Lechpammer M; Archer TC; Tran P; Reimer RJ; Cook JM; Lim M; Jensen FE; Pomeroy SL; Cho YJ
    Acta Neuropathol; 2014 Apr; 127(4):593-603. PubMed ID: 24196163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma.
    Chaturvedi NK; Mahapatra S; Kesherwani V; Kling MJ; Shukla M; Ray S; Kanchan R; Perumal N; McGuire TR; Sharp JG; Joshi SS; Coulter DW
    BMC Cancer; 2019 Nov; 19(1):1056. PubMed ID: 31694585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Icariin inhibits proliferation, migration, and invasion of medulloblastoma DAOY cells by regulation of SPARC.
    Yang Y; Li G
    Phytother Res; 2020 Mar; 34(3):591-600. PubMed ID: 32011040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells.
    Lin YH; Chiu JH; Tseng WS; Wong TT; Chiou SH; Yen SH
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):525-32. PubMed ID: 16172905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle.
    Murthy KS; Mahavadi S; Huang J; Zhou H; Sriwai W
    Am J Physiol Cell Physiol; 2008 Feb; 294(2):C477-87. PubMed ID: 18077607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1.
    Xu QF; Pan YW; Li LC; Zhou Z; Huang QL; Pang JC; Zhu XP; Ren Y; Yang H; Ohgaki H; Lv SQ
    Brain Pathol; 2014 Nov; 24(6):568-83. PubMed ID: 24576181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
    Andrade AF; Borges KS; Suazo VK; Geron L; Corrêa CA; Castro-Gamero AM; de Vasconcelos EJ; de Oliveira RS; Neder L; Yunes JA; Dos Santos Aguiar S; Scrideli CA; Tone LG
    Invest New Drugs; 2017 Feb; 35(1):26-36. PubMed ID: 27785591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-31 weakens cisplatin resistance of medulloblastoma cells via NF-κB and PI3K/AKT pathways.
    Ma H; Cao W; Ding M
    Biofactors; 2020 Sep; 46(5):831-838. PubMed ID: 32027070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.